Expanding Amyotrophic Lateral Sclerosis Genetic Spectrum via Systematic Screening of Adult-Onset Neurologic Disease Genes
Variant / mechanism
Pathogenic variants and short tandem repeat expansions in adult-onset neurologic disease genes, including non-ALS/FTD genes
Summary
Short-read genome sequencing was performed in 856 consecutively recruited patients with ALS or primary lateral sclerosis at an Italian tertiary centre (2013-2023), with systematic screening of 453 adult-onset neurologic disease genes for single-nucleotide variants, indels and short tandem repeat expansions. Overall, 168 patients (19.6%) carried a pathogenic or likely pathogenic variant or an expansion, 41 of them (4.8% of the cohort) in non-ALS/FTD genes: ataxias, neuropathies, myopathies, movement disorders, mitochondrial diseases and hereditary spastic paraplegias. Repeat expansions accounted for 11.9% of cases. A family history of ALS/FTD or other neurodegenerative disorders and earlier onset were enriched among carriers, but variants in upper motor neuron genes did not predict an upper motor neuron-predominant phenotype.
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
Nearly one ALS patient in twenty carries a pathogenic variant in a gene linked to another disease (ataxia, neuropathy, spastic paraplegia): an argument for interpreting the genome or exome against a broad gene list rather than a narrow ALS panel. Without a control cohort, the study cannot separate causal variants from incidental findings, as the authors acknowledge; each such result still needs case-by-case discussion.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime